Abstract
Methotrexate is a Folic Acid Antagonist and used as an Antineoplastic agent. In this study Methotrexate immediate release tablet is developed, which was stable and bioequivalent generic tablet formulation equivalent to innovator’s product. The developed tablet formulation shows similar dissolution and disintegration profile as that of innovator tablet. The immediate release tablet was prepared by Wet Granulation method. The in vitro release was carried out in 0.1N Hydrochloric Acid. The in-vitro release at 50 rpm showed similar dissolution profile when compared with the innovator tablet. The stability studies were carried out and there was no significant change in the drug content, assay, and DT and dissolution rate.
References
A. Dukic-Ott , J.P. Remon, P. Foreman, C. Vervaet, Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation, European Journal of Pharmaceutics and Biopharmaceutics 67 (2007) 715–724
J. Paroj, D. Vasiljevi, S. Ibri, Z. Djur, Tablet disintegration and drug dissolution in viscous media: Paracetamol IR tablets, International Journal of Pharmaceutics 355 (2008) 93–99
J. Wan, H. Xu, X. Yang, A new solid self microemulsifying formulation prepared by spray- drying to improve the oral bioavailability of poorly water soluble drugs, European Journal of Pharmaceutics and Biopharmaceutics 70 (2008) 439–444
G. Chawla, A.K. Bansal, Comparative assessment of solubility advantage from glassy and crystalline forms of a water-insoluble drug, European journal of pharmaceutical sciences 3 2 ( 2 0 0 7 ) 45–57
B.M. Lue, F.S. Nielsen, T. Magnussen, H.M. Schou, K. Kristensen, L.O. Jacobsen, Using biorelevant dissolution to obtain IVIVC of solid dosage forms containing a poorly-soluble model compound, European Journal of Pharmaceutics and Biopharmaceutics 69 (2008) 648–657
I.D. Roscaa, J.M. Vergnaudb, Evaluation of the characteristics of oral dosage forms with release controlled by erosion, Computers in Biology and Medicine 38 (2008) 668 – 675
I.J. Hardy, A.W. Baarup, C. Neri, P.V. Byway, Steven W. Booth, S. Fitzpatrick, Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone, International Journal of Pharmaceutics 337 (2007) 246–253
C.V. Liew, L. Gu, J.L. Soh, P.W. Heng, Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose., Pharm Res. 22(2005): 1387-98
N. Wyttenbach, C. Birringer, J. Alsenz, M. Kuentz, Drug-excipient compatibility testing using a high-throughput approach and statistical design, Pharm Dev Technol. 10 (2005): 499-505.
O. Schinzinger, P.C. Schmidt, Comparison of the granulation behavior of three different excipients in a laboratory fluidized bed granulator using statistical methods, Pharm Dev Technol. 10 (2005): 175-88.
E. Franceschinis, D Voinovich, M. Grassi, B. Perissutti,
G. Filipovic, J. Martinac, A. Meriani-Merlo, Self- emulsifying pellets prepared by wet granulation in high-shear mixer: influence of formulation variables and preliminary study on the in vitro absorption, Int J Pharm. 291 (2005): 87-97.
F. Kiekens, R. Zelko, J.P. Remon, A. Billon, B. Bataille,
G. Cassanas, M. Jacob, Influence of drying temperature and granulation liquid viscosity on the inter- and intragranular drug migration in tray- dried granules and compacts, Pharm Dev Technol. 5 (2000): 131-7.
A. Eugene, S. Barabas, M. Adeyeye, Crospovidone- analytical profiles of drug substances and excipients- vol 24-1996
J.J. Torrado, L.L. Augsburger, Effect of different excipients on the tableting of coated particles, International Journal of Pharmaceutics. 106 (lY94) 149-155
B. Wittgren, A. Larsson, Investigation of critical polymer properties for polymer release, swelling of matrix tablets, European Journal of Pharmaceutical Sciences (2008)
M.L. Chen, V. Shah, R. Patnaik, W. Adams, A. Hussain, D. Conner, M. Mehta, H. Malinowski, J. Lazor, S.M. Huang, D. Hare, L.Lesko, D. Sporn, Roger, Bioavailability and Bioequivalence: An FDA Regulatory Overview, Pharmaceutical Research.. 18 (2001) 123-128
J. Arnal, M. Bermejo, G.L. Amidon, H.E. Junginger, S. Kopp, K.K Midha, V.P. Shah, Biowaiver monographs for immediate release solid oral dosage forms: acyclovir,J Pharm Sci. 97 (2008) :5061-5073
L. Rebecca, L.A. Miller, A. Imran, The utility of cyclodextrins for enhancing oral bioavailability” Journal of Controlled Release 123 (2007) 78–99
T. Yasuji a, H. Takeuchi, Y. Kawashima, Particle design of poorly water-soluble drug substances using supercritical fluid technologies, Advanced Drug Delivery Reviews 60 (2008) 388–398
Disintegration. USP 28 NF 23.Asian edition.The official compendia of standards. United States Pharmacopoeial Convention, IncTwinbrook MD: 2410
Augsburger, Larry L, Zellhofer Mark J, 1996. Tablet Testing in James Swarbrick, James C. Boylan.Encyclopedia of Pharmaceutical Technology. Vol. XIV. Marcel Dekker. Inc. New York : 401-419.
Encyclopedia of Pharmaceutical Technology, 2th ed, James Swarbrick, James C Boylan, Marcel Dekker,2458-2480.
Hand book of Pharmaceutical Excipients, 4th ed, Raymond C Rowe, Paul J Sheskey, Pharmacuetical Press, 297,186,508.
Physicians desk reference, 59th ed., pg# 2855- 2860, 2005
The Merck Index, 13th ed., pg # 2350, 2001
FDA. Center for Drug Evaluation and Research (CDER).Guidance for Industry.Dissolution Testing of Immediate Release Solid Oral Dosage Forms. August 1997.
Guidance for Industry, ANDAs: Impurities in Drug Products, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, August 2005
Guidance for Industry, ANDAs: Impurities in Drug Substances, U.S. Department
T. M. S. Abu, B.T. Ajit, N.G. Rabin, G.H. Micheal,
A.R. Sunanda, R.M. Kenneth, A.V. Sailesh, Selection of solid dosage from composition through drug- excipient compatibility testing, Journal of Pharmaceutical Sciences88 (7) (2000) 696-704.
L.V. Allen, P.E. Lunear, Magnesium Stearate, Handbook of Pharmaceutical Excipients, American Pharmacists Association, 2215 Constitution Avenue, Washington D C, USA. Editors Raymond C Rowe, Paul J Sheskey and Sian C Owen, (1997) 280-282.
Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) 23rd ed. (2003) 5–22.
Augsburger, Larry L, Zellhofer Mark J, 1996. Tablet Testing in James Swarbrick, James C. Boylan.Encyclopedia of Pharmaceutical Technology. Vol. XIV. Marcel Dekker. Inc. New York: 401-419
Augsburger, Larry L, Zellhofer Mark J, Tablet Testing in James Swarbrick, James C. Boylan. Encyclopedia of Pharmaceutical Technology. Vol.
XIV. Marcel Dekker. Inc. New York, 1996, 401-419.
B. Hoener, L.Z. Benet, in: G.S. Banker, C.T. Rhodes (Eds.), Modern Pharmaceutics,Marcel Dekker, New York, (1990), 143.
Banker G S, Anderson N R. Tablets. In Lachman L, Liberman HA, Kanig JL.Editors. The Theory and Practice of Industrial Pharmacy, 3rd Edition. Varghese Publishing House, 1986, 293-345.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2020 Array